Normal nicotine content cigar

Phase 3Small molecule

OOhio State University Comprehensive Cancer Center

Normal nicotine content cigar is one of 4 small molecule programs targeting Addiction. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AddictionRecruiting

AddictionPhase 3

Recruiting

Competition

Competitive Landscape

5 competitors in Addiction

#DrugCompanyPhaseTrials

Ozempic

Novo Nordisk

Phase 2

2 2

Ketalar

AAultman Health Foundation

Phase 2

1 3

Normal nicotine content cigar

OOhio State University Comprehensive Cancer Center

Phase 3

1 4

Medication Optimization

VVA Office of Research and Development

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

Post-ApprovalRecruiting

Addiction

NCT06630728

Clinical

Trials by Indication[1]

Addiction1 trial

Addiction Potential of Very Low Nicotine Filtered Little Cigars

Recruiting·OOhio State University Comprehensive Cancer Center·Phase 4·NCT06630728·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Normal nicotine content cigar. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Normal nicotine content cigar compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Normal nicotine content cigar. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ohio State University Comprehensive Cancer Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: OOhio State University Comprehensive Cancer Center

Normal nicotine content cigar

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Addiction1 trial

References

Drug Info

Quick Facts

Related News